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Barriers in Conventional Research
Medical knowledge, culminating from the collection and translation of patient data, is the 
primary objective of the clinical research paradigm. The successful conduct of this 
traditional model has become even more challenging with expansion of costs and a 
dwindling research infrastructure. Beyond systemic issues, conventional research methods 
are further burdened by minimal patient engagement, inadequate staffing, and geographic 
limitations to recruitment. Clinical research has also failed to keep pace with patient 
demands, and the limited scope of well-funded, disease-specific investigation has left many 
patients feeling disenfranchised. Social media venues may represent a viable option to 
surpass these current and evolving barriers when used as an adjunctive approach to 
traditional clinical investigation.
The term social media (SM) most commonly refers to relatively public Internet-based 
communication platforms that enable users to consume and disseminate information. The 
most popular SM venues currently include Facebook, Twitter, YouTube, and independent 
online forums (Table 1). These digital platforms support sharing multiple forms of media 
including text, images, and videos between users that interact within a wide realm of 
medical groups and genres (e.g. specific diseases, symptoms, etc.). This collective 
“mediome”1 is a relatively untapped resource for clinical study, but research applications 
utilizing SM methodology have begun to produce real study benefits in an array of diseases. 
Effective implementation of this technology by interested investigators will require an in-
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depth working knowledge of digital venues beyond their own online social presence. A firm 
grasp of these applications can enable the contact of previously out-of-reach study 
participants, promote patient engagement and disease investment, and cultivate a community 
of interacting patients and researchers. This data-rich resource has already facilitated various 
aspects of biomedical studies, including dissemination of epidemiologic surveys2, direct 
recruitment into clinical trials3, collection of biologic samples4, and extraction of patient-
provided data all within SM platforms5.
Advantages and Pitfalls in SM Research
SM is a new frontier containing a wide spectrum of clinical and qualitative data from 
connected users (patients). Collection and examination of either individuals’ or groups’ SM 
information use can provide insight into qualitative life experiences, just as analysis of 
biologic samples can enable dissection of genetic disease underpinnings. This mediome is 
analogous to the human genome, both in content and utility.1 Analyzing data streams from 
SM for interpersonal interactions, message content, and even frequency can provide digital 
investigators with volumes of information that otherwise would remain unattainable.
There are many advantages to scientific interrogation of the social mediome, specifically as 
applications within SM have no physical bounds, encourage information exchange among 
stakeholders, and work in real time. Patient access to clinical studies and individual 
investment can limit both conventional and unconventional approaches to research. 
However, SM far exceeds the geographic limitations determined by location of patients and 
academic systems, thus expanding the available recruitment population dramatically (Table 
1). Patient-to-patient communication is facilitated by the format of most SM venues 
(Facebook and other Internet forums), thus creating an enriched collection of disease 
testimonies, symptom discussions, and treatment effects. In fact, patients frequently use SM 
to form online support groups in order to share experiences with similarly afflicted patients 
and families. These groups and their documented communications are valuable, as 
qualitative patient data can provide a high resolution of variable patient metrics to 
investigators.5 Lastly, data collection from SM can occur continuously in real time and with 
little cost. Facebook, Twitter, and YouTube are free to use, and while online Internet forums 
may incur small monetary investments (typically $15 to $50 per month). Because of study 
heterogeneity, it remains challenging to compare costs between a SM-based research study 
and a similar traditional clinic-based approach. Yet, historically, costs incurred to SM 
research pioneers have been dramatically lower than cost estimates of conventional 
approaches in the clinic.6
Several limitations and potential risks of SM for medical research should be addressed, 
including the possible compromise of privacy and confidentiality, the use and dissemination 
of medical advice and information, potential demographic biases, and a required trust of the 
investigator by patients. Many of these challenges can be similar to traditional methods, yet 
as in the conventional model, careful management can drastically reduce unwanted study 
issues.
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The risk of HIPAA violations must be seriously considered in the context of patient-
researcher interactions on SM. Because of the relatively public nature of these venues, 
patient confidentiality may be at risk if patients choose to divulge personal medical 
information. However, if proper protective measures are taken to ensure that the venue is 
secure (e.g., a private or closed group on Facebook or a by-invitation-only online Internet 
forum), and the researcher vets all patients who request entrance into the group, this risk 
may be minimized. Moreover, in order to further reduce any legal liability, the researcher 
should not provide any medical advice to patients who participate in a SM study. The drive 
to provide medical direction in study patients with need may be strong, as collaborative 
relationships between investigator and patients are likely to form. Furthermore, digital 
access to investigators on SM commonly becomes easy for patients. Safe approaches to 
communication could include redirecting patients to consult with their own doctor for 
advice, unbiased dissemination of disease-specific educational materials, or depiction of 
only institutional review board-approved study materials.7,8
An investigator-driven interactive community (e.g., Facebook group) may bolster patient 
involvement in SM studies and help facilitate disease-specific research. However, because 
most SM venues facilitate patient-patient interactions, misleading or incorrect medical 
information may be spread quickly between patients and could be misconstrued as official 
medical advice.9 In order to mitigate this, a researcher or trusted study personnel must 
actively moderate the digital venue in order to prevent the spread of counterproductive 
information.7 Although it is not possible to completely eliminate the sharing of unverified 
information, regular moderation will reduce the potentially negative impact of such sharing.
The perception that only younger populations use SM may appear to be a significant 
limitation for its implementation in clinical research. However, this limitation is rapidly 
becoming less significant, as recent studies have shown that the use of SM has become 
increasingly common among older adults. As of 2014, over half of the US adult population 
uses Facebook, including 73% and 63% of Internet-using adults age 30–49 and 50–64, 
respectively.10 SM may not be suitable for all diseases, yet there is likely significant 
demographic overlap for many disease populations.
Finally, it is imperative for researchers to gain the trust of patients on SM in order to 
effectively utilize these venues for research purposes. Because patient-researcher interaction 
does not occur face-to-face on these platforms, gaining the trust of patients may be more 
difficult than it would be in a clinical setting. Thus, patient-patient and patient-researcher 
communications within SM platforms must be carefully cultivated in order to instill 
participant confidence in the research being done on their behalf. Author CL has established 
a SM educational model for this exchange.4 Specifically, he provides patients with a 
distillation of current field research by posting updates in a research-specific Facebook 
group and on Twitter. This model not only empowers patients with disease education; it also 
solidifies the importance of patient investment in disease-specific research. Furthermore, 
invested patients bring ideas to research, take a more educated and proactive role in their 
care team, and ultimately return to seek more study involvement.
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A number of studies have shown SM methods to be an effective means of collecting data 
and improving quality of care for patients. One randomized controlled trial found that the 
use of SM to disseminate instructional information to patients alongside the traditional 
educational pamphlet increased patients’ quality of bowel preparation for colonoscopies.11 
Another study successfully utilized the Crohn’s and Colitis Foundation of America Partners 
Internet Cohort of more than 14,000 patients to examine factors associated with fiber 
consumption in inflammatory bowel disease and whether fiber was associated with disease 
flares.2 Additionally, several studies have assessed the roles of mobile apps, remote health 
sensors, and telemedicine in research and patient care and have found that these tools are 
effective at providing more complete care in real time and with decreased costs.12 Riaz and 
Atreja13 note that the most significant barrier to the use of these techniques in research and 
patient care is provider acceptability, in addition to the need for strict HIPAA compliance to 
ensure patient confidentiality. Keeping these limitations in mind, the aforementioned studies 
lend significant support to the effective use of SM as adjuncts to traditional clinical 
investigation.
SM in Rare Disease Research
Rare diseases (conditions with a prevalence of less than 200,000 patients in North America), 
in particular, are prime for high yield results and community impact using novel SM 
approaches. This is the result of established digital support groups, publications with 
historically low study numbers, and few focused investigators. Several studies of rare 
diseases have demonstrated considerable advantages of using SM as a study tool. For 
instance, an existing neuroendocrine cervical cancer Facebook support group was recently 
used to recruit a geographically widespread cohort of patients with this rare cancer. Through 
an online survey posted in the Facebook group, patients were able to provide specific 
information on their treatment, disease and symptom history, current disease status, and 
quality of life, including various psychological factors. Without the use of SM, collecting 
this information would have been virtually impossible, as the patients were treated at 51 
cancer centers across the country.14
Similarly, a 2014 study investigating Fontan-associated protein-losing enteropathy and 
plastic bronchitis aimed to compare patient participation in surveys posted on SM with 
participation in more traditional research modalities. The authors found that 84% of 
responses were referred from SM. As of 2014, this cohort was the largest known group of 
post-Fontan protein-losing enteropathy and plastic bronchitis patients in existence.15
Currently, the use of SM in hepatology research, specifically focused on autoimmune 
hepatitis (AIH), is under exploration at Indiana University. AIH is a rare autoimmune liver 
disease that results in immune-mediated destruction of liver cells, possibly resulting in 
fibrosis, cirrhosis, or liver failure if treatment is unsuccessful. Author CL has used both 
Facebook and Twitter to construct a large AIH study group of individuals affected with AIH 
called the Autoimmune Hepatitis Research Network (AHRN; 1500 members) during the 
past 2 years.4 Interested individuals have joined this research group after searching for AIH 
online support groups or reading shared AHRN posts on other media platforms. Between 
April 2015 and April 2016, there were posts by over 750 unique active members (>50% of 
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the group contributes to discussions), most of whom appear to be either caregivers of AIH 
patients or AIH patients themselves.
Preliminary informational analysis on this group has shown that CL and colleagues have 
been able to uncover rich clinical and non-clinical information that would otherwise remain 
unknown. This research was performed by semi-automated download of the Facebook 
group’s content and subsequent semantic analysis. Qualitative analysis was also performed 
by direct reading of patient narratives. Collected clinical information has included histories 
of medication side effects, familial autoimmune diseases, and comorbid conditions. The 
most common factors patients were unlikely to discuss with a provider (e.g., financial issues, 
employment, personal relationships, use of supplements, alcohol usage) were frequently 
discussed in the AHRN group, allowing a more transparent view of the complete disease 
experience.
Beyond research conducted in the current paradigm, the AHRN has provided a rich 
community construct where patients offer each other social support. The patient impression 
of AHRN on Facebook has been overwhelmingly positive, as patients often wonder why 
such a model has not been employed with other diseases. The close digital interaction CL 
has had with numerous patients and families has promoted other benefits of this 
methodology, as over 40 new AIH patients from outside Indiana have traveled to Indiana 
University for medical consultation despite no advertisement.
Conclusions
SM has the potential to transform healthcare research as a supplement to traditional research 
methods. Compared to a conventional research model, this methodology has proven to be 
cost- and time-effective, wide reaching, and similarly capable of data collection. Utilization 
of SM in research has tremendous potential to direct patient-centered research, as invested 
patient collaborators can take an active role in their own disease and may hone investigatory 
focus on stakeholder priorities. Limitations to this method are known, yet if implemented 
cautiously, these can be mitigated. Investment in and application of the social “mediome” by 
investigators and patients has the potential to support and transform research that would 
otherwise be impossible.
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Table 1
Statistics, Usage, Advantages, and Pitfalls of Social Media in Research
Facebook® Twitter® YouTube® Internet Forums
Official website www.facebook.com www.twitter.com www.youtube.com N/A
Available since 2004 (College students)2006 (General public) 2006 2005 Early 1990s
Operated By Facebook, Inc. Twitter, Inc. Google, Inc. Independent web server 
owners
Popularity
(Reach)
Best
(1 billion +)
Good
(100 million +)
Very Good
(800 million +)
No reliable estimate; not 
as popular but more 
targeted
Types of media 
supported
Typed text; images; 
embedded videos
“Tweets” (messages of up to 140 
characters); linked images; linked 
videos
Videos; some 
typed text in video 
comment sections
Typed text; linked images; 
linked videos
Customizability Very little Very little Very little Usually high
Financial cost Virtually zero Virtually zero Virtually zero Cost of a web server 
(typically $15–50 per 
month)
Data extraction difficulty Qualitative: Easy
Big data: Difficult
Qualitative: Easy
Big data: Difficult
Qualitative: Easy
Big data: Difficult
Qualitative and big data 
extraction are easy if the 
forum is database-driven
User privacy
Groups feature: 
Reasonable
Remainder of site: 
Marginal
(Users typically use real 
names)
Marginal/Reasonable (users 
typically use real names but may 
be masked by screen names)
Reasonable (users 
masked by screen 
names)
Best (can be kept 
completely private except 
to invited users only; users 
masked by screen names)
Communication direction Usually highly multilateral Somewhat multilateral; no formal 
post-reply structure
Relatively 
unilateral; users 
may post 
comments on 
videos
Usually highly Multilateral
Advantages for clinical 
research
Broad cohort of users; can 
form private groups
Quick, text-based communication Multimedia 
(audio/video) 
communication 
and feedback of 
health information
Privacy is easy to ensure; 
complete control of the 
venue; data extraction is 
simpler
Potential pitfalls for 
clinical research
Most users utilize real 
names on the site (Privacy 
risk)
Health discussions hampered by 
short (140 character) limit
Few chances for 
patient interaction 
(limited to 
comments)
Requires minor but non-
trivial technological 
support to set up; has 
financial costs
Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2018 May 01.
